CLINICAL_TRIALS
trial_result
· 2021-12-09
Clinical Trial Update: Empagliflozin Impact on Hemodynamics in Patients With Heart Failure [Phase 4]
Summary
Phase 4 trial investigating empagliflozin's impact on hemodynamics in patients with heart failure has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Saint Luke's Health System | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-12-09